Japan Society of Clinical Oncology Clinical Practice Guidelines 2017 for fertility preservation in childhood, adolescent, and young adult cancer patients: part 1.
Japan Society of Clinical Oncology Clinical Practice Guidelines 2017 for fertility preservation in childhood, adolescent, and young adult cancer patients: part 1.
复制标题
DOI：
10.1007/s10147-021-02081-w
复制
发表时间：
2022-03
影响因子：
3.3
通讯作者：
Suzuki N
中科院分区：
文献类型：
--
作者：
Harada M;Kimura F;Takai Y;Nakajima T;Ushijima K;Kobayashi H;Satoh T;Tozawa A;Sugimoto K;Saji S;Shimizu C;Akiyama K;Bando H;Kuwahara A;Furui T;Okada H;Kawai K;Shinohara N;Nagao K;Kitajima M;Suenobu S;Soejima T;Miyachi M;Miyoshi Y;Yoneda A;Horie A;Ishida Y;Usui N;Kanda Y;Fujii N;Endo M;Nakayama R;Hoshi M;Yonemoto T;Kiyotani C;Okita N;Baba E;Muto M;Kikuchi I;Morishige KI;Tsugawa K;Nishiyama H;Hosoi H;Tanimoto M;Kawai A;Sugiyama K;Boku N;Yonemura M;Hayashi N;Aoki D;Osuga Y;Suzuki N
2017年，日本临床肿瘤学会（JSCO）发布了《2017年JSCO儿童、青少年和青年癌症患者生育力保护临床实践指南》。这是日本第一个解决肿瘤生育问题的指南。在这一医学领域，肿瘤学家和生殖专家之间的持续密切合作是必不可少的，从癌症诊断到癌症治疗完成后的许多年。这些JSCO指南旨在指导多学科医务人员考虑生育力保存选项的可用性，并帮助他们决定是否在治疗开始前为儿童，青少年和年轻成年癌症患者提供生育力保存，最终目标是提高患者生存率。准则作为第1和第2部分提出。本文（第1部分）总结了指南的目标和用于制定指南的方法，并概述了所有肿瘤学领域的生育能力保护。它包括关于生育力保护的基本概念的一般性评论，以及按性别和治疗方式解释癌症治疗对性腺功能的影响，以及保护/保留性腺功能的选择，并根据4个临床问题提出建议。这些指南的第2部分提供了8种癌症（妇科、乳腺、泌尿、儿科、血液、骨和软组织、脑和消化）中生育力保留的具体建议。
In 2017, the Japan Society of Clinical Oncology (JSCO) published the JSCO Clinical Practice Guidelines 2017 for Fertility Preservation in Childhood, Adolescent, and Young Adult Cancer Patients. These were the first Japanese guidelines to address issues of oncofertility. In this field of medicine, sustained close cooperation between oncologists and reproductive specialists is essential from the diagnosis of cancer until many years after completion of cancer treatment. These JSCO guidelines were intended to guide multidisciplinary medical staff in considering the availability of fertility preservation options and to help them decide whether to provide fertility preservation to childhood, adolescent, and young adult cancer patients before treatment starts, with the ultimate goal of improving patient survivorship. The guidelines are presented as Parts 1 and 2. This article (Part 1) summarizes the goals of the guidelines and the methods used to develop them and provides an overview of fertility preservation across all oncology areas. It includes general remarks on the basic concepts surrounding fertility preservation and explanations of the impacts of cancer treatment on gonadal function by sex and treatment modality and of the options for protecting/preserving gonadal function and makes recommendations based on 4 clinical questions. Part 2 of these guidelines provides specific recommendations on fertility preservation in 8 types of cancer (gynecologic, breast, urologic, pediatric, hematologic, bone and soft tissue, brain, and digestive).
登录
查看更多内容
影响因子：
158.5
作者：
Gogas, H;Ioannovich, J;Kirkwood, JM
通讯作者：
Kirkwood, JM
DOI：
10.6004/jnccn.2017.0003
发表时间：
2017-01-01
影响因子：
13.4
作者：
Daly, Mary B.;Pilarski, Robert;Darlow, Susan
通讯作者：
Darlow, Susan
影响因子：
3.5
作者：
BOKEMEYER, C;SCHMOLL, HJ;POLIWODA, H
通讯作者：
POLIWODA, H
影响因子：
6.6
作者：
Arango, O;Bielsa, O;Mas, AG
通讯作者：
Mas, AG
影响因子：
6.7
作者：
Amato, Paula;Brzyski, Robert;Tipton, Sean
通讯作者：
Tipton, Sean